Tyler Gable, PhD
About Tyler Gable, PhD
Tyler Gable, PhD, is a Market Development Manager at Mettler-Toledo International, Inc, specializing in biologics and biopharmaceuticals. He has extensive experience in pre-clinical development and process technologies, with a focus on enhancing efficiency and quality in the life sciences sector.
Work at Mettler-Toledo International
Tyler Gable serves as the Market Development Manager for Biologics and Biopharmaceuticals at Mettler-Toledo International, Inc. since 2020. In this role, he focuses on the strategic development and execution of marketing initiatives related to biologics discoveries. His responsibilities include engaging in marketing content creation and publication for Process Analytical Technologies (PAT) in bioprocessing. Gable also acts as a global Subject Matter Expert (SME), providing support to industry partners and colleagues in biologics and biopharmaceutical workflows.
Education and Expertise
Tyler Gable holds a Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology from the University of Maryland Baltimore, which he completed from 2012 to 2017. He also earned two Bachelor of Science (BS) degrees in Biotechnology and Chemistry from Eastern Washington University between 2008 and 2012. His educational background equips him with a strong foundation in life sciences, particularly in the areas of biologics and biopharmaceuticals.
Background
Prior to his current role, Tyler Gable worked as a Technology Application Consultant in Bio & Reaction Engineering at Mettler-Toledo International from 2017 to 2020. He also gained experience as a Graduate Research Assistant at the University of Maryland, Baltimore, from 2012 to 2017. Earlier in his career, he served as a Quality Control Intern at Jubilant HollisterStier Contract Manufacturing & Services from 2009 to 2012.
Achievements in Biologics Development
Tyler Gable has conducted pre-clinical development of Protein Functional Effector small non-coding RNAs (pfeRNAs) aimed at creating preventative screening profiles for high-risk lung cancer populations. His work also explores the potential of these compounds as companion diagnostics and therapeutics. He has developed innovative process technologies that enhance the efficiency of biologic processes, contributing to faster market entry and improved quality in various sectors, including pharma, biotech, and agriculture.
Passion for Life Sciences and Healthcare
Tyler Gable exhibits a strong passion for strategy, creation, and execution in the realm of new biologics discoveries. His interests lie particularly in life sciences and healthcare applications, where he aims to drive advancements and innovations that can lead to improved patient outcomes and enhanced therapeutic options.